Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024:71:407-432.
doi: 10.1007/978-3-031-37936-9_19.

Mechanisms of Cell Fusion in Cancer

Affiliations
Review

Mechanisms of Cell Fusion in Cancer

Felicite K Noubissi et al. Results Probl Cell Differ. 2024.

Abstract

Cell-cell fusion is a normal physiological mechanism that requires a well-orchestrated regulation of intracellular and extracellular factors. Dysregulation of this process could lead to diseases such as osteoporosis, malformation of muscles, difficulties in pregnancy, and cancer. Extensive literature demonstrates that fusion occurs between cancer cells and other cell types to potentially promote cancer progression and metastasis. However, the mechanisms governing this process in cancer initiation, promotion, and progression are less well-studied. Fusogens involved in normal physiological processes such as syncytins and associated factors such as phosphatidylserine and annexins have been observed to be critical in cancer cell fusion as well. Some of the extracellular factors associated with cancer cell fusion include chronic inflammation and inflammatory cytokines, hypoxia, and viral infection. The interaction between these extracellular factors and cell's intrinsic factors potentially modulates actin dynamics to drive the fusion of cancer cells. In this review, we have discussed the different mechanisms that have been identified or postulated to drive cancer cell fusion.

Keywords: Actin; Cancer cell fusion; Cytokines; Extracellular factors; Fusogens; HERV env; Hypoxia; Inflammation; Phosphatidylserine; Signaling pathways; Syncytin; Viral infection.

PubMed Disclaimer

Similar articles

References

    1. Abu-Thuraia Afnan, Gauthier Rosemarie, Chidiac Rony, Fukui Yoshinori, Screaton Robert A., Gratton Jean-Philippe, and Côté Jean-François. 2015. ‘Axl Phosphorylates Elmo Scaffold Proteins To Promote Rac Activation and Cell Invasion’. Molecular and Cellular Biology 35(1). doi:10.1128/mcb.00764-14. - DOI - PMC - PubMed
    1. Adler RR, Ng AK, and Rote NS. 1995. ‘Monoclonal Antiphosphatidylserine Antibody Inhibits Intercellular Fusion of the Choriocarcinoma Line, JAR’. Biology of Reproduction 53(4). doi: 10.1095/biolreprod53.4.905. - DOI - PubMed
    1. Aghababaei M, Hogg K, Perdu S, Robinson WP, and Beristain AG. 2015. ‘ADAM12-Directed Ectodomain Shedding of E-Cadherin Potentiates Trophoblast Fusion’. Cell Death and Differentiation 22(12). doi: 10.1038/cdd.2015.44. - DOI - PMC - PubMed
    1. Aguilar Pablo S., Baylies Mary K., Fleissner Andre, Helming Laura, Inoue Naokazu, Podbilewicz Benjamin, Wang Hongmei, and Wong Melissa. 2013. ‘Genetic Basis of Cell-Cell Fusion Mechanisms’. Trends in Genetics 29(7). - PMC - PubMed
    1. Aguirre Luis Augusto, Montalbán-Hernández Karla, Avendaño-Ortiz José, Marín Elvira, Lozano Roberto, Toledano Víctor, Sánchez-Maroto Laura, Terrón Verónica, Valentín Jaime, Pulido Elisa, Casalvilla José Carlos, Rubio Carolina, Diekhorst Luke, Laso-García Fernando, del Fresno Carlos, Collazo-Lorduy Ana, Jiménez-Munarriz Beatriz, Gómez-Campelo Paloma, Llanos-González Emilio, Fernández-Velasco María, Rodríguez-Antolín Carlos, de Diego Rebeca Pérez, Cantero-Cid Ramón, Hernádez-Jimenez Enrique, Álvarez Enrique, Rosas Rocío, López-Ayllón Blanca dies, de Castro Javier, Wculek Stefanie K., Cubillos-Zapata Carolina, de Cáceres Inmaculada Ibáñez, Díaz-Agero Prudencio, Fernández María Gutiérrez, de Miguel María Paz, Sancho David, Schulte Leon, Perona Rosario, Belda-Iniesta Cristóbal, Boscá Lisardo, and López-Collazo Eduardo. 2020. ‘Tumor Stem Cells Fuse with Monocytes to Form Highly Invasive Tumor-Hybrid Cells’. OncoImmunology 9(1). doi: 10.1080/2162402X.2020.1773204. - DOI - PMC - PubMed

LinkOut - more resources